5 signs your pricing strategy is signaling weakness

5 signs your pricing strategy is signaling weakness

[ad_1] Pricing feels deceptively simple until you are the one staring at Stripe dashboards at midnight, wondering whether your numbers say confidence or desperation. Most founders obsess over product, growth, and fundraising before they ever interrogate pricing. That is understandable. Pricing forces you to confront how much you really believe in what you are building…

Read More

Consequences Founders Face When Ignoring Finances

Consequences Founders Face When Ignoring Finances

[ad_1] At some point in the founder journey, almost everyone has the same quiet realization. You are working nonstop, revenue is coming in, money is going out, but you cannot clearly explain where the business is actually winning or bleeding. You glance at your bank balance instead of your financials and tell yourself you will…

Read More

Pfizer beats Q4 profit estimates on strong drug demand

Pfizer beats Q4 profit estimates on strong drug demand

[ad_1] Robust demand for its heart and oncology drugs helped achieve total sales for the quarter of US$17.56 billion Published Tue, Feb 3, 2026 · 09:21 PM [WASHINGTON] Pfizer on Tuesday (Feb 3) reported fourth-quarter profit above Wall Street estimates, as sustained demand for older drugs such as blood thinner Eliquis helped offset fading sales…

Read More

How to make Singapore equities great again? Step up investor education, says Chee Hong Tat

How to make Singapore equities great again? Step up investor education, says Chee Hong Tat

[ad_1] Guardrails will be put in place where necessary to protect against downside risk, the Monetary Authority of Singapore deputy chairman adds [SINGAPORE] Singapore will devote more resources to public and investor education as part of efforts to revitalise the equities market, said Monetary Authority of Singapore deputy chairman and Minister for National Development Chee…

Read More